Recipients of the Pharmacy Practice Research Award

2009
“Enhanced Photoemission Spectroscopy for Verification of High-Risk I.V. Medications”
Yaman Kaakeh, Pharm.D., BCPS, Hanna Phan, Pharm.D., Brian D. DeSmet, Pharm.D., M.S., Deborah A. Pasko, Pharm.D., Denise K. Glenn, B.S.Pharm., and James G. Stevenson, Pharm.D
Am J Health-Syst Pharm 2008;65:49-54.
Purdue University
West Lafayette, Ind.

2008
“Clinical and economic outcomes of pharmacist managed antimicrobial prophylaxis in surgical patients”
C.A. (CAB) Bond, Pharm.D., and Cynthia L. Raehl, Pharm.D.
American Journal of Health-System Pharmacy 2007; 64:1935-1942.
Texas Tech University Health Sciences Center, School of Pharmacy
Amarillo, TX

2007
“Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol”
Jeannie K. Lee, Pharm.D., Karen A. Grace, Pharm.D., and Allen J. Taylor, M.D.
Journal of the American Medical Association 2006; 296:2563-2571.
Walter Reed Army Medical Center
Washington, DC

"This award is significant because it is an effective way to highlight the FAME Study and its comprehensive pharmacy care program. FAME was the first trial to examine the strategies to improve elderly patients' adherence to chronic polypharmacy, and clinical pharmacists were the key players in creating and implementing the adherence program." 
-- Jeannie K. Lee

2006
“Clinical and Economic Outcomes of Pharmacist-Managed Aminoglycoside or Vancomycin Therapy”
C.A. (CAB) Bond, Pharm.D., FASHP, FCCP, and Cynthia L. Raehl, Pharm.D., FASHP, FCCP
AJHP 2005; 62:1596-1605
Texas Tech University Health Sciences Center-Amarillo

2005
“Effect of a Centralized Clinical Pharmacy Anticoagulation Service on the Outcomes of Anticoagulation Therapy”
Daniel M. Witt, Pharm.D., FCCP; Melanie Sadler, Pharm.D.; Roberta Shanahan, Pharm.D.; Georgann Mazzoli, Pharm.D.; Donald J. Tillman, Pharm.D.
CHEST 2005;127:1515-1522
Kaiser Permamente Colorado, Westminster
Kaiser Permamente Ohio Region, Cleveland

2004
“Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine Units”
Suzan N. Kucakarslan, Ph.D.; Michael Peters, R.Ph., BCPS; Mark Mlynarek, R.Ph., BCPS; Daniel A. Nafziger, M.D., M.S.
Arch Intern Med/Vol 163, Sep 22, 2003
Henry Ford Hospital, Detroit, MI

2003
"Cost/Death Averted With Venous Thromboembolism Prophylaxis in Patients Undergoing Total Knee Replacement or Knee Arthroplasty"
William E. Wade, Pharm.D., FCCP; Jayanti Nerurkar, M.S.; and Bradley C. Martin, Pharm.D., Ph.D.
University of Georgia, College of Pharmacy, Athens, GA

2002
"Effect of Vaccination by Community Pharmacists Among Adult Prescription Recipients"
John D. Grabenstein, Ph.D., Anthrax Vaccine Immunization Program, U.S. Army Medical Command, Falls Church, VA; Harry A. Guess, M.D., Ph.D., Merck Research Laboratories, Blue Bell, PA; Abraham G. Hartzema, Pharm.D., University of Florida, Gainesville, FL; Gary G. Koch, Ph.D., University of North Carolina, Chapel Hill, NC; T. Robert Konrad, Ph.D., Sheps Center for Health Services Research, University of North Carolina, Chapel Hill.
Medical Care 2001; 39(4):340-48.

2001
"Quality of Pharmacotherapy Consultations Provided by Drug Information Centers in the United States"
Karim Anton Calis, Pharm.D., M.P.H., FASHP; Dallas W. Anderson, Ph.D.; Doris A. Auth, Pharm.D.; David A. Mays, Pharm.D.; Nannette M. Turcasso, Pharm.D.; Christine C. Meyer, Pharm.D.; and Linda R. Young, Pharm.D., National Institutes of Health, Bethesda, MD.
Pharmacotherapy 2000; 20: 830-836.

2000
"Clinical Pharmacy Services, Pharmacist Staffing and Drug Costs in United States Hospitals"
C.A. (CAB) Bond, Pharm.D., FASHP, FCCP; Cynthia L. Raehl, Pharm.D., FASHP; and Todd Franke, Ph.D.
Pharmacotherapy, 1999; 19[12]:1354-62.
Texas Tech University Health Sciences Center, School of Pharmacy
Amarillo, TX

1999
"The Kaiser Permanente/USC Patient Consultation Study: Change in Use and Cost of Health Care Services; Change in Quality of Life; Patient Satisfaction with Pharmaceutical Services"
Jeffrey S. McCombs, Ph.D.; Kathleen Johnson, Ph.D.; and Marisue Cody, Ph.D., R.N.
University of Southern California
Los Angeles, CA

1998
"Pharmacoeconomic Model of Enoxaparin Versus Heparin for Prevention of Deep Vein Thrombosis After Total Hip Replacement"
David W. Hawkins, Pharm.D., University of Georgia, Athens; Paul C. Langley, Ph.D.; and Kem P. Krueger, Pharm.D., Ph.D., Center for Pharmaceutical Economics, University of Arizona, Tucson
American Journal of Health-System Pharmacy, May 15, 1997.

1997
"Behavioral Pharmaceutical Care Scale for Measuring Pharmacists' Activities"
Folakemi T. Odedina, Ph.D., and Richard Segal, Ph.D.
American Journal of Health-System Pharmacy, April 15, 1996.

1996
"Drug-Related Morbidity and Mortality, A Cost of Illness Model"
Jeffrey A. Johnson, Ph.D., Institute of Pharmacoeconomics, Edmonton, Alberta, Canada; and J. Lyle Bootman, Ph.D., Arizona Health Sciences Center and Center for Pharmaceutical Economics, The University of Arizona, Tucson.
Arch Intern Med, 1995; 155:1949-56.

1995
"Antidepressant Pharmacotherapy: Economic Outcomes in a Health Maintenance Organization"
David A. Sclar, Linda M. Robison, and Tracy L. Skaer, Washington State University, Pullman; Randall F. Legg and Neil L. Nemec, Qual-Med Health Plan of Washington, Spokane; Richard S. Galin, Pullman Memorial Hospital, Pullman, WA; and Tom E. Hughes and Don P. Buesching, Eli Lilly & Company, Indianapolis, IN.
Clinical Therapeutics, April 1994.

1994
"Effect of Pharmacists on Health Care Outcomes in Hospitalized Patients"
Darrel C. Bjornson, William O. Hiner, Jr., Roger P. Potyk, Bruce A. Nelson, Frederic A. Lombardo, Tracy A. Morton, Lydia V. Larson, Brian P. Martin, Robert G. Sikora, and Frank A. Cammarata.
American Journal of Hospital Pharmacy, September 1993, pp. 1875-84.
Walter Reed Army Medical Center
Washington, DC

1993
"Decision Analysis to Assess Cost-Effectiveness of Low-Osmolality Contrast Medium for Intravenous Urography"
M. Victoria Calvo, M. Pilar del Val, M. Mar Alvarez, and A. Dominguez-Gil.
American Journal of Hospital Pharmacy, March 1992, pp. 577-584.
Clinical Hospital of Salamanca
Salamanca, Spain


Prior to the establishment of the Drug Therapy Research Award and the Professional Practice Research Award in 1993, there was only one category: the Research Award. To see a list of the recipients of the Research Award, 1971 - 1992), click here.
From: 
Email:  
To: 
Email:  
Subject: 
Message: